I agree that this site is using cookies. You can find further informations here.
X
Obi, Shuntaro
93  results:
Search for persons X
?
1

Nomograms should be noted:

Obi, Shuntaro ; Omata, Masao
Hepatology International.  18 (2024)  2 - p. 420-421 , 2024
Link: https://doi.org/10.1007/..
 
?
2

The incidence of all organ malignancies and overall surviva..:

Obi, Shuntaro ; Kanda, Miho ; Ooka, Yoshihiko...
Hepatology International.  17 (2023)  3 - p. 562-572 , 2023
Link: https://doi.org/10.1007/..
 
?
3

A study on prevention of bleeding complications using lusut..:

Yoshida, Hideo ; Ohki, Takamasa ; Kanezaki, Mineo...
BMC Gastroenterology.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
4

Clinical Practice Guidelines for Hepatic Arterial Infusion ..:

Ueshima, Kazuomi ; Komemushi, Atsushi ; Aramaki, Takeshi...
Liver Cancer.  11 (2022)  5 - p. 407-425 , 2022
Link: https://doi.org/10.1159/..
 
?
5

Effectiveness of direct acting antiviral agents for hepatit..:

Ohki, Takamasa ; Sato, Koki ; Kondo, Mayuko...
Journal of Viral Hepatitis.  28 (2021)  11 - p. 1597-1603 , 2021
Link: https://doi.org/10.1111/..
 
?
6

Liver dysfunction of Atezolizumab + Bevacizumab ‐a matter o..:

Obi, Shuntaro ; Omata, Masao
Liver International.  41 (2021)  7 - p. 1702-1703 , 2021
Link: https://doi.org/10.1111/..
 
?
7

The Use of Electronic Medical Records-Based Big-Data Inform..:

Amano, Hiroyuki ; Kanda, Tatsuo ; Mochizuki, Hitoshi...
Viruses.  13 (2021)  11 - p. 2216 , 2021
Link: https://doi.org/10.3390/..
 
?
8

Relationship between outcomes and relative dose intensity o..:

Ohki, Takamasa ; Sato, Koki ; Kondo, Mayuko...
Liver Research.  4 (2020)  4 - p. 199-205 , 2020
Link: https://doi.org/10.1016/..
 
?
9

Impact of Adverse Events on the Progression-Free Survival o..:

Ohki, Takamasa ; Sato, Koki ; Kondo, Mayuko...
Drugs - Real World Outcomes.  7 (2020)  2 - p. 141-149 , 2020
Link: https://doi.org/10.1007/..
 
?
10

Clinical Features and Liver Injury in Patients with COVID-1..:

Abe, Koichiro ; Yamamoto, Takatsugu ; Matsumoto, Kotaro...
Internal Medicine.  59 (2020)  19 - p. 2353-2358 , 2020
Link: https://doi.org/10.2169/..
 
?
11

Hepatic Arterial Infusion Chemotherapy versus Sorafenib in ..:

Ueshima, Kazuomi ; Ogasawara, Sadahisa ; Ikeda, Masafumi...
Liver Cancer.  9 (2020)  5 - p. 583-595 , 2020
Link: https://doi.org/10.1159/..
 
?
12

The efficacy and safety of lenvatinib for advanced hepatoce..:

Obi, Shuntaro ; Sato, Takahisa ; Sato, Shinpei...
Hepatology International.  13 (2019)  2 - p. 199-204 , 2019
Link: https://doi.org/10.1007/..
 
?
13

Objective Response by mRECIST Is an Independent Prognostic ..:

Kudo, Masatoshi ; Ueshima, Kazuomi ; Chiba, Yasutaka...
Liver Cancer.  8 (2019)  6 - p. 505-519 , 2019
Link: https://doi.org/10.1159/..
 
?
14

Multicenter, randomized, controlled trial of S‐1 monotherap..:

Nagano, Hiroaki ; Obi, Shuntaro ; Hatano, Etsuro...
Hepatology Research.  48 (2018)  9 - p. 717-726 , 2018
Link: https://doi.org/10.1111/..
 
?
15

Regional Differences in Efficacy, Safety, and Biomarkers fo..:

Kudo, Masatoshi ; Kang, Yoon-Koo ; Park, Joong-Won...
Liver Cancer.  7 (2017)  2 - p. 148-164 , 2017
Link: https://doi.org/10.1159/..
 
1-15